Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis

Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis

Abstract Background In multiple sclerosis, coagulation factors have been shown to modulate inflammation. In this translational study, we investigated whether long-term anticoagulation with warfarin or rivaroxaban has beneficial effects on the course of autoimmune experimental encephalomyelitis (EAE)...

Descrizione completa

Dettagli Bibliografici
Autori principali: Leonie Stolz, Amin Derouiche, Kavi Devraj, Frank Weber, Robert Brunkhorst, Christian Foerch
Natura: Articolo
Lingua:English
Pubblicazione: BMC 2017-07-01
Serie:Journal of Neuroinflammation
Soggetti:
Multiple sclerosis
Experimental autoimmune encephalomyelitis
Inflammation
Mice
Anticoagulation
Accesso online:http://link.springer.com/article/10.1186/s12974-017-0926-2

Accesso online

http://link.springer.com/article/10.1186/s12974-017-0926-2

Documenti analoghi